DRUG BINDING INTERFACES MAPPED TO 'PROTEIN KINASE'
List of Binding Interfaces (Click on the entry ID to view details of interfaces and pattern clusters) (Note that ASSAM search use only 3-12 residue containing patterns)DrReposER ID | PDB | Ligand | Organism | Macromolecule | Pfam | Res. | Interface | HETATM |
---|---|---|---|---|---|---|---|---|
1FMO_E_ADNE351 | 1fmo | ADN DB00640(Adenosine) | Mus musculus;Oryctolaguscuniculus | CAMP-DEPENDENTPROTEIN KINASE;HEAT STABLE RABBITSKELETAL MUSCLEINHIBITOR PROTEIN | PF00069(Pkinase)PF02827(PKI) | 14 | ARG I 18LEU E 49GLY E 50VAL E 57ALA E 70VAL E 104TYR E 122VAL E 123GLU E 127ASN E 171LEU E 173THR E 183ASP E 184PHE E 327 | ADN E 351 |
1IEP_A_STIA201 | 1iep | STI DB00619(Imatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL | PF07714(Pkinase_Tyr) | 18 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271GLU A 286VAL A 289MET A 290VAL A 299ILE A 313THR A 315PHE A 317MET A 318GLY A 321ARG A 362LEU A 370ALA A 380ASP A 381 | STI A 201 |
1IEP_B_STIB202 | 1iep | STI DB00619(Imatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL | no annotation | 19 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321ARG B 362LEU B 370ALA B 380ASP B 381 | STI B 202 |
1OPJ_A_STIA3 | 1opj | STI DB00619(Imatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 17 | LEU A 267TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305VAL A 308MET A 309ILE A 312VAL A 318ILE A 332THR A 334PHE A 336MET A 337LEU A 389ALA A 399ASP A 400 | STI A 3 |
1OPJ_B_STIB4 | 1opj | STI DB00619(Imatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU B 267TYR B 272VAL B 275ALA B 288LYS B 290GLU B 305VAL B 308MET B 309ILE B 312VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340ARG B 381ALA B 399ASP B 400 | STI B 4 |
1Q97_B_ADNB486 | 1q97 | ADN DB00640(Adenosine) | Saccharomycescerevisiae | SR PROTEIN KINASE | no annotation | 4 | VAL B 172ALA B 185LEU B 226PHE B 246 | ADN B 486 |
1UWH_A_BAXA1723 | 1uwh | BAX DB00398(Sorafenib) | Homo sapiens | B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE | PF07714(Pkinase_Tyr) | 18 | ILE A 462VAL A 470ALA A 480GLU A 500VAL A 503LEU A 504ILE A 512LEU A 513THR A 528TRP A 530CYS A 531LEU A 566ILE A 571HIS A 573PHE A 582GLY A 592ASP A 593PHE A 594 | BAX A1723 |
1UWH_B_BAXB1723 | 1uwh | BAX DB00398(Sorafenib) | Homo sapiens | B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE | no annotation | 18 | ILE B 462VAL B 470ALA B 480LYS B 482GLU B 500VAL B 503LEU B 504ILE B 512LEU B 513THR B 528TRP B 530CYS B 531LEU B 566ILE B 571HIS B 573PHE B 582GLY B 592ASP B 593 | BAX B1723 |
1UWJ_A_BAXA1723 | 1uwj | BAX DB00398(Sorafenib) | Homo sapiens | B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE | PF07714(Pkinase_Tyr) | 19 | ILE A 462VAL A 470ALA A 480LYS A 482GLU A 500LEU A 504THR A 507ILE A 512LEU A 513THR A 528TRP A 530CYS A 531LEU A 566ILE A 571HIS A 573GLY A 592ASP A 593PHE A 594SER A 601 | BAX A1723 |
1UWJ_B_BAXB1723 | 1uwj | BAX DB00398(Sorafenib) | Homo sapiens | B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE | no annotation | 15 | ILE B 462VAL B 470ALA B 480GLU B 500ILE B 512LEU B 513THR B 528TRP B 530CYS B 531LEU B 566HIS B 573GLY B 592ASP B 593PHE B 594LYS B 600 | BAX B1723 |
1XBB_A_STIA1 | 1xbb | STI DB00619(Imatinib) | Homo sapiens | TYROSINE-PROTEINKINASE SYK | PF07714(Pkinase_Tyr) | 9 | LEU A 377VAL A 385ALA A 400MET A 448MET A 450ALA A 451GLY A 454PRO A 455LEU A 501 | STI A 1 |
1YI4_A_ADNA306 | 1yi4 | ADN DB00640(Adenosine) | Homo sapiens | PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE PIM-1 | PF00069(Pkinase) | 10 | LEU A 44PHE A 49ALA A 65ILE A 104LEU A 120ARG A 122PRO A 123ASP A 128LEU A 174ILE A 185 | ADN A 306 |
2EUF_B_LQQB401 | 2euf | LQQ DB09073(Palbociclib) | Homo sapiens | CELL DIVISIONPROTEIN KINASE 6 | PF00069(Pkinase) | 12 | ILE B 19VAL B 27LYS B 43VAL B 77PHE B 98VAL B 101ASP B 104THR B 107ASN B 150LEU B 152ALA B 162ASP B 163 | LQQ B 401 |
2FUM_A_MIXA539 | 2fum | MIX DB01204(Mitoxantrone) | Mycobacteriumtuberculosis | PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB | PF00069(Pkinase) | 14 | LEU A 17GLY A 18VAL A 25ALA A 38TYR A 94VAL A 95ASP A 102ASP A 138LYS A 140ALA A 142ASN A 143MET A 145MET A 155ASP A 156 | MIX A 539 |
2FUM_B_MIXB1539 | 2fum | MIX DB01204(Mitoxantrone) | Mycobacteriumtuberculosis | PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB | no annotation | 12 | LEU B 17GLY B 18VAL B 25ALA B 38MET B 92TYR B 94VAL B 95LYS B 140ASN B 143MET B 145MET B 155ASP B 156 | MIX B1539 |
2FUM_C_MIXC2539 | 2fum | MIX DB01204(Mitoxantrone) | Mycobacteriumtuberculosis | PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB | no annotation | 13 | LEU C 17GLY C 18VAL C 25ALA C 38MET C 92TYR C 94VAL C 95THR C 99ASP C 102ASN C 143MET C 145MET C 155ASP C 156 | MIX C2539 |
2FUM_D_MIXD3539 | 2fum | MIX DB01204(Mitoxantrone) | Mycobacteriumtuberculosis | PROBABLESERINE/THREONINE-PROTEIN KINASE PKNB | no annotation | 15 | LEU D 17GLY D 18GLY D 20VAL D 25ALA D 38MET D 92VAL D 95VAL D 98THR D 99ASP D 138LYS D 140ASN D 143MET D 145MET D 155ASP D 156 | MIX D3539 |
2GQG_A_1N1A501 | 2gqg | 1N1 DB01254(Dasatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 14 | LEU A 248TYR A 253ALA A 269LYS A 271GLU A 286MET A 290VAL A 299ILE A 313THR A 315PHE A 317MET A 318GLY A 321LEU A 370ALA A 380 | 1N1 A 501 |
2GQG_B_1N1B502 | 2gqg | 1N1 DB01254(Dasatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 14 | LEU B 248VAL B 256ALA B 269LYS B 271GLU B 286MET B 290VAL B 299ILE B 313THR B 315MET B 318TYR B 320GLY B 321LEU B 370ALA B 380 | 1N1 B 502 |
2HYY_A_STIA600 | 2hyy | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 18 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293VAL A 299ILE A 313THR A 315PHE A 317GLY A 321ARG A 362LEU A 370ALA A 380ASP A 381 | STI A 600 |
2HYY_B_STIB600 | 2hyy | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321LEU B 370ALA B 380ASP B 381 | STI B 600 |
2HYY_C_STIC600 | 2hyy | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU C 248TYR C 253VAL C 256ALA C 269LYS C 271GLU C 286VAL C 289MET C 290ILE C 293VAL C 299ILE C 313THR C 315PHE C 317MET C 318GLY C 321LEU C 370ALA C 380ASP C 381 | STI C 600 |
2HYY_D_STID600 | 2hyy | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 16 | LEU D 248TYR D 253VAL D 256ALA D 269LYS D 271GLU D 286MET D 290ILE D 293VAL D 299ILE D 313THR D 315PHE D 317MET D 318LEU D 370ALA D 380ASP D 381 | STI D 600 |
2IVU_A_ZD6A3015 | 2ivu | ZD6 DB05294(Vandetanib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RETPRECURSOR | PF07714(Pkinase_Tyr) | 15 | LEU A 730GLY A 731VAL A 738ALA A 756LYS A 758GLU A 775LEU A 779LEU A 802VAL A 804TYR A 806ALA A 807GLY A 810LEU A 881SER A 891ASP A 892 | ZD6 A3015 |
2OIQ_A_STIA1001 | 2oiq | STI DB00619(Imatinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 17 | LEU A 273VAL A 281ALA A 293LYS A 295GLU A 310VAL A 313MET A 314LEU A 317ILE A 336THR A 338TYR A 340MET A 341GLY A 344ARG A 385LEU A 393ALA A 403ASP A 404 | STI A1001 |
2PL0_A_STIA200 | 2pl0 | STI DB00619(Imatinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE LCK | PF07714(Pkinase_Tyr) | 14 | VAL A 259ALA A 271LYS A 273GLU A 288LEU A 291MET A 292VAL A 301ILE A 314THR A 316TYR A 318MET A 319LEU A 371ALA A 381ASP A 382 | STI A 200 |
2XP2_A_VGHA9000 | 2xp2 | VGH DB08865(Crizotinib) | Homo sapiens | TYROSINE-PROTEINKINASE RECEPTOR | PF07714(Pkinase_Tyr) | 9 | LEU A1122VAL A1130ALA A1148LEU A1196MET A1199GLY A1202LEU A1256GLY A1269ASP A1270 | VGH A9000 |
2YFX_A_VGHA9000 | 2yfx | VGH DB08865(Crizotinib) | Homo sapiens | TYROSINE-PROTEINKINASE RECEPTOR | PF07714(Pkinase_Tyr) | 8 | LEU A1122ALA A1148MET A1196MET A1199GLY A1202LEU A1256GLY A1269ASP A1270 | VGH A9000 |
2ZVA_A_1N1A513 | 2zva | 1N1 DB01254(Dasatinib) | Mus musculus | TYROSINE-PROTEINKINASE LYN | PF07714(Pkinase_Tyr) | 12 | LEU A 253ALA A 273LYS A 275GLU A 290MET A 294VAL A 303ILE A 317THR A 319MET A 322GLY A 325LEU A 374ALA A 384 | 1N1 A 513 |
3BBT_B_FMMB91 | 3bbt | FMM DB01259(Lapatinib) | Homo sapiens | RECEPTORTYROSINE-PROTEINKINASE ERBB-4 | PF07714(Pkinase_Tyr) | 14 | VAL B 707ALA B 724LYS B 726MET B 747LEU B 758LEU B 769THR B 771LEU B 773GLY B 777LEU B 825THR B 835ASP B 836PHE B 837LEU B 839 | FMM B 91 |
3BBT_D_FMMD91 | 3bbt | FMM DB01259(Lapatinib) | Homo sapiens | RECEPTORTYROSINE-PROTEINKINASE ERBB-4 | no annotation | 13 | VAL D 707ALA D 724LYS D 726MET D 747LEU D 769THR D 771MET D 774GLY D 777LEU D 825THR D 835ASP D 836PHE D 837LEU D 839 | FMM D 91 |
3CS9_A_NILA600 | 3cs9 | NIL DB04868(Nilotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 22 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271LYS A 285GLU A 286VAL A 289MET A 290ILE A 293LEU A 298VAL A 299ILE A 313THR A 315PHE A 317GLY A 321PHE A 359HIS A 361LEU A 370VAL A 379ALA A 380ASP A 381 | NIL A 600 |
3CS9_B_NILB600 | 3cs9 | NIL DB04868(Nilotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 21 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293LEU B 298VAL B 299ILE B 313THR B 315GLY B 321PHE B 359HIS B 361LEU B 370VAL B 379ALA B 380ASP B 381PHE B 382 | NIL B 600 |
3CS9_C_NILC600 | 3cs9 | NIL DB04868(Nilotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 21 | LEU C 248TYR C 253VAL C 256ALA C 269LYS C 271GLU C 286VAL C 289MET C 290ILE C 293LEU C 298VAL C 299ILE C 313THR C 315PHE C 317MET C 318PHE C 359HIS C 361VAL C 379ALA C 380ASP C 381PHE C 382 | NIL C 600 |
3CS9_D_NILD600 | 3cs9 | NIL DB04868(Nilotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU D 248TYR D 253VAL D 256ALA D 269LYS D 271GLU D 286VAL D 289MET D 290ILE D 293LEU D 298THR D 315PHE D 317GLY D 321PHE D 359HIS D 361LEU D 370ALA D 380ASP D 381 | NIL D 600 |
3EYG_A_MI1A1 | 3eyg | MI1 DB08895(Tofacitinib) | Homo sapiens | TYROSINE-PROTEINKINASE | PF07714(Pkinase_Tyr) | 12 | LEU A 881GLY A 882GLY A 884GLY A 887VAL A 889ALA A 906LYS A 908MET A 956SER A 963ASN A1008LEU A1010ASP A1021 | MI1 A 1 |
3FUP_A_MI1A1 | 3fup | MI1 DB08895(Tofacitinib) | Homo sapiens | TYROSINE-PROTEINKINASE JAK2 | PF07714(Pkinase_Tyr) | 13 | LEU A 855GLY A 856GLY A 858GLY A 861VAL A 863ALA A 880LYS A 882MET A 929TYR A 931SER A 936ASN A 981LEU A 983ASP A 994 | MI1 A 1 |
3FUP_B_MI1B1 | 3fup | MI1 DB08895(Tofacitinib) | Homo sapiens | TYROSINE-PROTEINKINASE JAK2 | no annotation | 13 | LEU B 855GLY B 856GLY B 858VAL B 863ALA B 880LYS B 882VAL B 911MET B 929TYR B 931LEU B 932ASN B 981LEU B 983ASP B 994 | MI1 B 1 |
3G5D_A_1N1A1 | 3g5d | 1N1 DB01254(Dasatinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 14 | LEU A 273VAL A 281ALA A 293LYS A 295GLU A 310MET A 314VAL A 323ILE A 336THR A 338TYR A 340MET A 341GLY A 344LEU A 393ALA A 403 | 1N1 A 1 |
3G5D_B_1N1B1 | 3g5d | 1N1 DB01254(Dasatinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | no annotation | 14 | LEU B 273VAL B 281ALA B 293LYS B 295GLU B 310MET B 314VAL B 323ILE B 336THR B 338TYR B 340MET B 341GLY B 344LEU B 393ALA B 403 | 1N1 B 1 |
3GCS_A_BAXA401 | 3gcs | BAX DB00398(Sorafenib) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 14 | PF00069(Pkinase) | 18 | VAL A 38ALA A 51ARG A 70GLU A 71LEU A 74LEU A 75MET A 78VAL A 83ILE A 84THR A 106LEU A 108MET A 109ILE A 141ILE A 146HIS A 148ILE A 166LEU A 167ASP A 168 | BAX A 401 |
3GP0_A_NILA1 | 3gp0 | NIL DB04868(Nilotinib) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 11 | PF00069(Pkinase) | 19 | VAL A 38ALA A 51LYS A 53ARG A 67GLU A 71LEU A 74LEU A 75VAL A 83ILE A 84LEU A 104THR A 106LEU A 108MET A 109HIS A 148ALA A 157ILE A 166LEU A 167ASP A 168PHE A 169 | NIL A 1 |
3GVU_A_STIA1001 | 3gvu | STI DB00619(Imatinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL2 | PF07714(Pkinase_Tyr) | 17 | LEU A 294TYR A 299VAL A 302ALA A 315LYS A 317GLU A 332VAL A 335MET A 336ILE A 339VAL A 345ILE A 359THR A 361TYR A 363MET A 364LEU A 416ALA A 426ASP A 427 | STI A1001 |
3GVU_A_STIA1002 | 3gvu | STI DB00619(Imatinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL2 | PF07714(Pkinase_Tyr) | 8 | ALA A 383VAL A 384LEU A 386LEU A 387ALA A 479GLY A 509PRO A 511VAL A 514 | STI A1002 |
3HEC_A_STIA1 | 3hec | STI DB00619(Imatinib) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 14 | PF00069(Pkinase) | 16 | VAL A 30ALA A 51LYS A 53GLU A 71LEU A 74LEU A 75ILE A 84LEU A 104THR A 106LEU A 108MET A 109ILE A 146ASP A 150LEU A 167ASP A 168PHE A 169 | STI A 1 |
3HEG_A_BAXA1 | 3heg | BAX DB00398(Sorafenib) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 14 | PF00069(Pkinase) | 18 | VAL A 30VAL A 38ALA A 51LYS A 53GLU A 71LEU A 74LEU A 75MET A 78VAL A 83ILE A 84THR A 106MET A 109ILE A 141ILE A 146HIS A 148ILE A 166LEU A 167ASP A 168 | BAX A 1 |
3IK3_A_0LIA1 | 3ik3 | 0LI DB08901(Ponatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 19 | LEU A 248TYR A 253ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293LEU A 298VAL A 299ILE A 313ILE A 315MET A 318HIS A 361ARG A 362LEU A 370ALA A 380ASP A 381PHE A 382 | 0LI A 1 |
3IK3_B_0LIB2 | 3ik3 | 0LI DB08901(Ponatinib) | Mus musculus | PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1 | no annotation | 19 | LEU B 248TYR B 253ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293LEU B 298VAL B 299ILE B 313ILE B 315MET B 318HIS B 361ARG B 362LEU B 370ALA B 380ASP B 381PHE B 382 | 0LI B 2 |
3K54_A_1N1A1 | 3k54 | 1N1 DB01254(Dasatinib) | Homo sapiens | TYROSINE-PROTEINKINASE BTK | PF07714(Pkinase_Tyr) | 13 | LEU A 408ALA A 428LYS A 430GLU A 445MET A 449VAL A 458ILE A 472THR A 474TYR A 476MET A 477GLY A 480LEU A 528SER A 538 | 1N1 A 1 |
3K5V_A_STIA2 | 3k5v | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 18 | LEU A 267TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305VAL A 308MET A 309ILE A 312VAL A 318ILE A 332THR A 334PHE A 336MET A 337GLY A 340LEU A 389ALA A 399ASP A 400 | STI A 2 |
3K5V_B_STIB2 | 3k5v | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU B 267TYR B 272VAL B 275ALA B 288LYS B 290GLU B 305VAL B 308MET B 309ILE B 312VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340LEU B 389ALA B 399ASP B 400 | STI B 2 |
3LFA_A_1N1A361 | 3lfa | 1N1 DB01254(Dasatinib) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 14 | PF00069(Pkinase) | 8 | VAL A 30ALA A 51LYS A 53GLU A 71LEU A 104THR A 106LEU A 108MET A 109 | 1N1 A 361 |
3LXK_A_MI1A1125 | 3lxk | MI1 DB08895(Tofacitinib) | Homo sapiens | TYROSINE-PROTEINKINASE JAK3 | PF07714(Pkinase_Tyr) | 13 | LEU A 828GLY A 829VAL A 836ALA A 853LYS A 855VAL A 884MET A 902TYR A 904CYS A 909ASN A 954LEU A 956ALA A 966ASP A 967 | MI1 A1125 |
3LXN_A_MI1A1 | 3lxn | MI1 DB08895(Tofacitinib) | Homo sapiens | NON-RECEPTORTYROSINE-PROTEINKINASE TYK2 | PF07714(Pkinase_Tyr) | 13 | LEU A 903GLY A 904GLY A 906VAL A 911ALA A 928LYS A 930ILE A 960TYR A 980VAL A 981SER A 985ASN A1028LEU A1030ASP A1041 | MI1 A 1 |
3MIY_A_B49A1 | 3miy | B49 DB01268(Sunitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ITK/TSK | PF07714(Pkinase_Tyr) | 11 | ILE A 369ALA A 389LYS A 391VAL A 419PHE A 435PHE A 437MET A 438GLY A 441LEU A 489SER A 499ASP A 500 | B49 A 1 |
3MIY_B_B49B2 | 3miy | B49 DB01268(Sunitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ITK/TSK | no annotation | 9 | ILE B 369ALA B 389LYS B 391PHE B 435PHE B 437MET B 438GLY B 441LEU B 489SER B 499 | B49 B 2 |
3MS9_A_STIA1 | 3ms9 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 18 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293VAL A 299ILE A 313THR A 315PHE A 317MET A 318ARG A 362LEU A 370ALA A 380ASP A 381 | STI A 1 |
3MS9_B_STIB1 | 3ms9 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 19 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321ARG B 362LEU B 370ALA B 380ASP B 381 | STI B 1 |
3MSS_A_STIA1 | 3mss | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 18 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293VAL A 299ILE A 313THR A 315PHE A 317MET A 318ARG A 362LEU A 370ALA A 380ASP A 381 | STI A 1 |
3MSS_B_STIB1 | 3mss | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 19 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271GLU B 286VAL B 289MET B 290ILE B 293VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321ARG B 362LEU B 370ALA B 380ASP B 381 | STI B 1 |
3MSS_C_STIC1 | 3mss | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU C 248TYR C 253VAL C 256ALA C 269LYS C 271GLU C 286VAL C 289MET C 290ILE C 293VAL C 299ILE C 313THR C 315PHE C 317MET C 318ARG C 362LEU C 370ALA C 380ASP C 381 | STI C 1 |
3MSS_D_STID1 | 3mss | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | no annotation | 18 | LEU D 248TYR D 253VAL D 256ALA D 269LYS D 271GLU D 286VAL D 289MET D 290ILE D 293VAL D 299ILE D 313THR D 315PHE D 317MET D 318GLY D 321LEU D 370ALA D 380ASP D 381 | STI D 1 |
3OCT_A_1N1A663 | 3oct | 1N1 DB01254(Dasatinib) | Homo sapiens | TYROSINE-PROTEINKINASE BTK | PF07714(Pkinase_Tyr) | 17 | LEU A 408PHE A 413VAL A 416ALA A 428LYS A 430MET A 449VAL A 458ILE A 472THR A 474TYR A 476MET A 477ASN A 479GLY A 480GLU A 488LEU A 528SER A 538PHE A 540 | 1N1 A 663 |
3OEZ_A_STIA601 | 3oez | STI DB00619(Imatinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 17 | VAL A 281ALA A 293LYS A 295GLU A 310VAL A 313MET A 314ILE A 317VAL A 323ILE A 336THR A 338TYR A 340MET A 341GLY A 344ARG A 385LEU A 393ALA A 403ASP A 404 | STI A 601 |
3OEZ_B_STIB601 | 3oez | STI DB00619(Imatinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | no annotation | 14 | VAL B 281ALA B 293LYS B 295GLU B 310VAL B 313MET B 314ILE B 336THR B 338TYR B 340MET B 341ARG B 385LEU B 393ALA B 403ASP B 404 | STI B 601 |
3OXZ_A_0LIA1 | 3oxz | 0LI DB08901(Ponatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 21 | LEU A 248TYR A 253ALA A 269LYS A 271GLU A 286VAL A 289MET A 290ILE A 293LEU A 298VAL A 299ILE A 313THR A 315MET A 318GLY A 321HIS A 361ARG A 362LEU A 370VAL A 379ALA A 380ASP A 381PHE A 382 | 0LI A 1 |
3PP1_A_ACTA590 | 3pp1 | ACT DB03166(Aceticacid) | Homo sapiens | DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1 | PF00069(Pkinase) | 5 | GLU A 62LEU A 63GLN A 116HIS A 119GLY A 131 | ACT A 590 |
3QLG_A_1N1A601 | 3qlg | 1N1 DB01254(Dasatinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 14 | LEU A 273VAL A 281ALA A 293LYS A 295GLU A 310MET A 314VAL A 323ILE A 336THR A 338TYR A 340MET A 341GLY A 344LEU A 393ALA A 403 | 1N1 A 601 |
3QLG_B_1N1B601 | 3qlg | 1N1 DB01254(Dasatinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | no annotation | 16 | LEU B 273VAL B 281ALA B 293LYS B 295GLU B 310MET B 314VAL B 323ILE B 336THR B 338TYR B 340MET B 341LYS B 343GLY B 344LEU B 393ALA B 403ASP B 404 | 1N1 B 601 |
3SOA_A_DB8A445 | 3soa | DB8 DB06616(Bosutinib) | Homo sapiens | CALCIUM/CALMODULIN-DEPENDENT PROTEINKINASE TYPE IISUBUNIT ALPHA WITH ABETA 7 LINKER | PF00069(Pkinase)PF08332(CaMKII_AD) | 6 | LEU A 19VAL A 27MET A 42PHE A 89VAL A 92PHE A 157 | DB8 A 445 |
3SXR_A_1N1A1 | 3sxr | 1N1 DB01254(Dasatinib) | Homo sapiens | CYTOPLASMICTYROSINE-PROTEINKINASE BMX | PF07714(Pkinase_Tyr) | 14 | LEU A 423VAL A 431ALA A 443LYS A 445MET A 464VAL A 473ILE A 487THR A 489TYR A 491ILE A 492GLY A 495LEU A 543SER A 553PHE A 555 | 1N1 A 1 |
3SXR_B_1N1B2 | 3sxr | 1N1 DB01254(Dasatinib) | Homo sapiens | CYTOPLASMICTYROSINE-PROTEINKINASE BMX | no annotation | 13 | LEU B 423VAL B 431ALA B 443LYS B 445MET B 464VAL B 473THR B 489TYR B 491ILE B 492GLY B 495LEU B 543SER B 553PHE B 555 | 1N1 B 2 |
3UE4_A_DB8A601 | 3ue4 | DB8 DB06616(Bosutinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 12 | LEU A 248ALA A 269LYS A 271GLU A 286VAL A 299ILE A 313THR A 315PHE A 317MET A 318GLY A 321LEU A 370PHE A 382 | DB8 A 601 |
3UE4_B_DB8B601 | 3ue4 | DB8 DB06616(Bosutinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | no annotation | 14 | LEU B 248VAL B 256ALA B 269LYS B 271GLU B 286MET B 290VAL B 299ILE B 313THR B 315PHE B 317MET B 318GLY B 321LEU B 370PHE B 382 | DB8 B 601 |
3ZBF_A_VGHA3000 | 3zbf | VGH DB08865(Crizotinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE ROS | PF07714(Pkinase_Tyr) | 12 | LEU A1951ALA A1978LEU A2010LEU A2026LEU A2028MET A2029GLY A2032ASP A2033THR A2036LEU A2086GLY A2101ASP A2102 | VGH A3000 |
4AN2_A_EUIA1382 | 4an2 | EUI DB05239(Cobimetinib) | Homo sapiens | DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1 | PF00069(Pkinase) | 16 | ASN A 78LYS A 97LEU A 115LEU A 118ILE A 141MET A 143ASP A 190LYS A 192ASN A 195ASP A 208GLY A 210VAL A 211SER A 212LEU A 215GLY A 225THR A 226 | EUI A1382 |
4C8B_A_0LIA1000 | 4c8b | 0LI DB08901(Ponatinib) | Homo sapiens | RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2 | PF07714(Pkinase_Tyr) | 17 | VAL A 32ALA A 45LYS A 47GLU A 66LEU A 70ILE A 78LEU A 79ILE A 93THR A 95TYR A 97MET A 98HIS A 144LEU A 153ILE A 162ALA A 163ASP A 164PHE A 165 | 0LI A1000 |
4C8B_B_0LIB1000 | 4c8b | 0LI DB08901(Ponatinib) | Homo sapiens | RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2 | no annotation | 15 | ALA B 45LYS B 47GLU B 66LEU B 70ILE B 78LEU B 79THR B 95TYR B 97MET B 98HIS B 144LEU B 153ILE B 162ALA B 163ASP B 164PHE B 165 | 0LI B1000 |
4CKI_A_ADNA2022 | 4cki | ADN DB00640(Adenosine) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET | PF07714(Pkinase_Tyr) | 11 | LEU A 730GLY A 731GLY A 733VAL A 738ALA A 756VAL A 804TYR A 806ALA A 807GLY A 810SER A 811LEU A 881 | ADN A2022 |
4CKJ_A_ADNA2014 | 4ckj | ADN DB00640(Adenosine) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET | PF07714(Pkinase_Tyr) | 10 | LEU A 730GLY A 731GLY A 733VAL A 738ALA A 756VAL A 804TYR A 806ALA A 807SER A 811LEU A 881 | ADN A2014 |
4DRH_A_RAPA201 | 4drh | RAP DB00877(Sirolimus) | Homo sapiens | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5;SERINE/THREONINE-PROTEIN KINASE MTOR | PF00254(FKBP_C)PF08771(FRB_dom) | 21 | TYR A 57ASP A 68HIS A 71PHE A 77GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113LYS A 121ILE A 122PHE A 130LEU B2031SER B2035ARG B2036PHE B2039THR B2098TRP B2101ASP B2102TYR B2105PHE B2108 | RAP A 201 |
4DRH_D_RAPD201 | 4drh | RAP DB00877(Sirolimus) | Homo sapiens | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5;SERINE/THREONINE-PROTEIN KINASE MTOR | PF08771(FRB_dom)no annotation | 22 | TYR D 57ASP D 68HIS D 71PHE D 77GLN D 85VAL D 86ILE D 87TRP D 90TYR D 113PRO D 120ILE D 122PHE D 130GLU B2022LEU E2031SER E2035ARG E2036PHE E2039THR E2098TRP E2101ASP E2102TYR E2105PHE E2108 | RAP D 201 |
4DRI_A_RAPA201 | 4dri | RAP DB00877(Sirolimus) | Homo sapiens | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5;SERINE/THREONINE-PROTEIN KINASE MTOR | PF00254(FKBP_C)PF08771(FRB_dom) | 21 | TYR A 57ASP A 68ARG A 73PHE A 77GLN A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130LEU B2031GLU B2032SER B2035ARG B2036PHE B2039THR B2098TRP B2101ASP B2102TYR B2105PHE B2108 | RAP A 201 |
4DRJ_A_RAPA201 | 4drj | RAP DB00877(Sirolimus) | Homo sapiens | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4;SERINE/THREONINE-PROTEIN KINASE MTOR | PF00254(FKBP_C)PF08771(FRB_dom) | 19 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113LYS A 121ILE A 122PHE A 130LEU B2031SER B2035PHE B2039THR B2098TRP B2101ASP B2102TYR B2105PHE B2108 | RAP A 201 |
4FVQ_A_ACTA903 | 4fvq | ACT DB03166(Aceticacid) | Homo sapiens | TYROSINE-PROTEINKINASE JAK2 | PF07714(Pkinase_Tyr) | 4 | ASN A 673CYS A 675ARG A 715TRP A 718 | ACT A 903 |
4FVQ_A_ACTA904 | 4fvq | ACT DB03166(Aceticacid) | Homo sapiens | TYROSINE-PROTEINKINASE JAK2 | PF07714(Pkinase_Tyr) | 3 | PHE A 560VAL A 582GLU A 621 | ACT A 904 |
4I41_A_MIXA500 | 4i41 | MIX DB01204(Mitoxantrone) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE PIM-1 | PF00069(Pkinase) | 16 | LEU A 44PHE A 49VAL A 52ALA A 65ILE A 104LEU A 120GLN A 127ASP A 128ASP A 131ASP A 167LYS A 169GLU A 171ASN A 172LEU A 174ILE A 185ASP A 186 | MIX A 500 |
4I41_A_MIXA501 | 4i41 | MIX DB01204(Mitoxantrone) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE PIM-1 | PF00069(Pkinase) | 12 | ILE A 133THR A 134LYS A 169ASP A 170THR A 204VAL A 206ASP A 234ASP A 239ILE A 240GLU A 243GLU A 247ARG A 256 | MIX A 501 |
4IAA_A_RTZA401 | 4iaa | RTZ DB00679(Thioridazine) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE PIM-1 | PF00069(Pkinase) | 11 | PHE A 49VAL A 52ALA A 65LYS A 67LEU A 120VAL A 126ASP A 128GLU A 171LEU A 174ILE A 185ASP A 186 | RTZ A 401 |
4IFG_A_1E8A601 | 4ifg | 1E8 DB09053(Ibrutinib) | Toxoplasma gondii | CALMODULIN-DOMAINPROTEIN KINASE 1 | PF00069(Pkinase)PF13499(EF-hand_7) | 14 | GLY A 58VAL A 65ALA A 78LYS A 80MET A 112LEU A 114LEU A 126TYR A 131GLY A 134GLU A 135LEU A 181ILE A 194ASP A 195LEU A 198 | 1E8 A 601 |
4KS8_A_B49A701 | 4ks8 | B49 DB01268(Sunitinib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE PAK 6 | PF00069(Pkinase) | 10 | ILE A 413ALA A 434VAL A 465MET A 481PHE A 483LEU A 484GLY A 487LEU A 533SER A 543ASP A 544 | B49 A 701 |
4LMN_A_EUIA503 | 4lmn | EUI DB05239(Cobimetinib) | Homo sapiens | DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1 | PF00069(Pkinase) | 15 | LYS A 97LEU A 115LEU A 118ILE A 141MET A 143ASP A 190ASN A 195ASP A 208PHE A 209GLY A 210VAL A 211SER A 212LEU A 215MET A 219ASN A 221 | EUI A 503 |
4MXO_A_DB8A601 | 4mxo | DB8 DB06616(Bosutinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 14 | LEU A 273VAL A 281ALA A 293LYS A 295GLU A 310MET A 314VAL A 323ILE A 336THR A 338TYR A 340MET A 341GLY A 344LEU A 393ASP A 404 | DB8 A 601 |
4MXO_B_DB8B601 | 4mxo | DB8 DB06616(Bosutinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | no annotation | 13 | LEU B 273VAL B 281ALA B 293LYS B 295GLU B 310VAL B 323ILE B 336THR B 338TYR B 340MET B 341GLY B 344LEU B 393ASP B 404 | DB8 B 601 |
4MXX_A_DB8A601 | 4mxx | DB8 DB06616(Bosutinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 13 | LEU A 273ALA A 293LYS A 295GLU A 310MET A 314VAL A 323ILE A 336THR A 338TYR A 340MET A 341GLY A 344LEU A 393THR A 403 | DB8 A 601 |
4MXX_B_DB8B601 | 4mxx | DB8 DB06616(Bosutinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | no annotation | 12 | LEU B 273VAL B 281ALA B 293LYS B 295VAL B 323THR B 338TYR B 340MET B 341GLY B 344LEU B 393THR B 403PHE B 405 | DB8 B 601 |
4MXY_A_DB8A601 | 4mxy | DB8 DB06616(Bosutinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 13 | LEU A 273VAL A 281ALA A 293LYS A 295GLU A 310VAL A 323ILE A 336MET A 338TYR A 340MET A 341GLY A 344LEU A 393ASP A 404 | DB8 A 601 |
4MXY_B_DB8B601 | 4mxy | DB8 DB06616(Bosutinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | no annotation | 13 | LEU B 273VAL B 281ALA B 293LYS B 295GLU B 310VAL B 323MET B 338TYR B 340MET B 341GLY B 344LEU B 393ALA B 403ASP B 404 | DB8 B 601 |
4MXZ_A_DB8A601 | 4mxz | DB8 DB06616(Bosutinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 13 | LEU A 273VAL A 281ALA A 293LYS A 295GLU A 310VAL A 323ILE A 336MET A 338TYR A 340MET A 341GLY A 344LEU A 393ASP A 404 | DB8 A 601 |
4MXZ_B_DB8B601 | 4mxz | DB8 DB06616(Bosutinib) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | no annotation | 13 | LEU B 273VAL B 281ALA B 293LYS B 295GLU B 310VAL B 323MET B 338TYR B 340MET B 341GLY B 344LEU B 393ALA B 403ASP B 404 | DB8 B 601 |
4OTI_A_MI1A1001 | 4oti | MI1 DB08895(Tofacitinib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE N1 | PF00069(Pkinase)PF00433(Pkinase_C) | 14 | LEU A 627GLY A 628GLY A 630GLY A 633VAL A 635ALA A 648LYS A 650VAL A 685TYR A 703ASN A 751LEU A 753ALA A 763ASP A 764PHE A 910 | MI1 A1001 |
4OTW_A_DB8A1101 | 4otw | DB8 DB06616(Bosutinib) | Homo sapiens | RECEPTORTYROSINE-PROTEINKINASE ERBB-3 | PF07714(Pkinase_Tyr) | 15 | LEU A 696VAL A 704CYS A 721LYS A 723VAL A 753LEU A 766THR A 768TYR A 770LEU A 771GLY A 774ASN A 820LEU A 822ALA A 832ASP A 833VAL A 836 | DB8 A1101 |
4QMN_A_DB8A401 | 4qmn | DB8 DB06616(Bosutinib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE 24 | PF00069(Pkinase) | 13 | ILE A 30ALA A 51LYS A 53GLU A 70THR A 83ILE A 97MET A 99TYR A 101LEU A 102LEU A 151ALA A 161ASP A 162LYS A 295 | DB8 A 401 |
4QMS_A_1N1A401 | 4qms | 1N1 DB01254(Dasatinib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE 24 | PF00069(Pkinase) | 11 | ILE A 30LYS A 32ALA A 51LYS A 53GLU A 70ILE A 97MET A 99TYR A 101LEU A 102LEU A 151ASP A 162 | 1N1 A 401 |
4QMZ_A_B49A401 | 4qmz | B49 DB01268(Sunitinib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE 24 | PF00069(Pkinase) | 12 | ILE A 30GLY A 31VAL A 38ALA A 51THR A 83MET A 99TYR A 101LEU A 102GLY A 103LEU A 151TYR A 291LYS A 295 | B49 A 401 |
4RZ7_A_1E8A901 | 4rz7 | 1E8 DB09053(Ibrutinib) | Plasmodium vivax | CGMP-DEPENDENTPROTEIN KINASE,PUTATIVE | PF00027(cNMP_binding)PF00069(Pkinase) | 10 | ILE A 540ALA A 561LYS A 563THR A 586ILE A 595PHE A 609THR A 611LEU A 613VAL A 614LEU A 664 | 1E8 A 901 |
4RZV_A_032A801 | 4rzv | 032 DB08881(Vemurafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | PF07714(Pkinase_Tyr) | 17 | ILE A 463VAL A 471ALA A 481LYS A 483LEU A 514PHE A 516ILE A 527THR A 529TRP A 531CYS A 532SER A 535SER A 536HIS A 539PHE A 583GLY A 593PHE A 595GLY A 596 | 032 A 801 |
4RZV_B_032B801 | 4rzv | 032 DB08881(Vemurafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | no annotation | 17 | ILE B 463VAL B 471ALA B 481LYS B 483LEU B 514PHE B 516THR B 529TRP B 531CYS B 532SER B 535SER B 536HIS B 539PHE B 583GLY B 593ASP B 594PHE B 595GLY B 596 | 032 B 801 |
4TWP_A_AXIA601 | 4twp | AXI DB06626(Axitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 12 | LEU A 248TYR A 253VAL A 256ALA A 269LYS A 271PHE A 317MET A 318GLY A 321ASN A 368LEU A 370ALA A 380ASP A 381 | AXI A 601 |
4TWP_B_AXIB601 | 4twp | AXI DB06626(Axitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | no annotation | 12 | LEU B 248TYR B 253VAL B 256ALA B 269LYS B 271PHE B 317MET B 318GLY B 321ASN B 368LEU B 370ALA B 380ASP B 381 | AXI B 601 |
4U5J_A_RXTA601 | 4u5j | RXT DB08877(Ruxolitinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | PF07714(Pkinase_Tyr) | 11 | LEU A 273GLY A 276VAL A 281ALA A 293TYR A 340MET A 341GLY A 344ASN A 391LEU A 393ALA A 403ASP A 404 | RXT A 601 |
4U5J_B_RXTB601 | 4u5j | RXT DB08877(Ruxolitinib) | Gallus gallus | PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC | no annotation | 9 | LEU B 273VAL B 281ALA B 293LYS B 295TYR B 340MET B 341GLY B 344LEU B 393ASP B 404 | RXT B 601 |
4WA9_A_AXIA9000 | 4wa9 | AXI DB06626(Axitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 11 | LEU A 248TYR A 253ALA A 269LYS A 271THR A 315MET A 318GLY A 321ASN A 368LEU A 370ALA A 380PHE A 382 | AXI A9000 |
4WA9_B_AXIB9000 | 4wa9 | AXI DB06626(Axitinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | no annotation | 12 | TYR B 253VAL B 256ALA B 269LYS B 271THR B 315PHE B 317MET B 318GLY B 321ASN B 368LEU B 370ALA B 380PHE B 382 | AXI B9000 |
4XEY_A_1N1A601 | 4xey | 1N1 DB01254(Dasatinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 15 | LEU A 267VAL A 275ALA A 288LYS A 290MET A 309VAL A 318ILE A 332THR A 334PHE A 336MET A 337GLY A 340LEU A 389ALA A 399ASP A 400PHE A 401 | 1N1 A 601 |
4XEY_B_1N1B601 | 4xey | 1N1 DB01254(Dasatinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | no annotation | 15 | LEU B 267VAL B 275ALA B 288LYS B 290MET B 309VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340LEU B 389ALA B 399ASP B 400PHE B 401 | 1N1 B 601 |
4XOY_A_DX4A401 | 4xoy | DX4 DB00352(Tioguanine) | Rattus norvegicus | MITOGEN-ACTIVATEDPROTEIN KINASE 1 | PF00069(Pkinase) | 6 | ALA A 50LYS A 52GLN A 103LEU A 105MET A 106LEU A 154 | DX4 A 401 |
4XP3_A_DX4A401 | 4xp3 | DX4 DB00352(Tioguanine) | Rattus norvegicus | MITOGEN-ACTIVATEDPROTEIN KINASE 1 | PF00069(Pkinase) | 6 | ALA A 50LYS A 52GLN A 103LEU A 105MET A 106LEU A 154 | DX4 A 401 |
4XV2_A_P06A801 | 4xv2 | P06 DB08912(Dabrafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | PF07714(Pkinase_Tyr) | 16 | GLY A 466PHE A 468VAL A 471ALA A 481LYS A 483LEU A 505LEU A 514PHE A 516ILE A 527THR A 529TRP A 531CYS A 532PHE A 583GLY A 593ASP A 594PHE A 595 | P06 A 801 |
4XV2_B_P06B801 | 4xv2 | P06 DB08912(Dabrafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | no annotation | 16 | GLY B 466PHE B 468VAL B 471ALA B 481LYS B 483LEU B 505LEU B 514PHE B 516ILE B 527THR B 529TRP B 531CYS B 532PHE B 583GLY B 593ASP B 594PHE B 595 | P06 B 801 |
5AJQ_A_DB8A800 | 5ajq | DB8 DB06616(Bosutinib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE 10 | PF00069(Pkinase) | 16 | LEU A 42GLY A 43VAL A 50ALA A 63LYS A 65ILE A 110PHE A 112CYS A 113GLY A 116GLU A 124ASN A 162LEU A 164ALA A 174ASP A 175VAL A 178SER A 179 | DB8 A 800 |
5AJQ_B_DB8B800 | 5ajq | DB8 DB06616(Bosutinib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE 10 | no annotation | 10 | LEU B 42ALA B 63LYS B 65ILE B 110PHE B 112CYS B 113GLY B 116LEU B 164ALA B 174ASP B 175 | DB8 B 800 |
5CSW_A_P06A801 | 5csw | P06 DB08912(Dabrafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | PF07714(Pkinase_Tyr) | 15 | PHE A 468VAL A 471ALA A 481LYS A 483LEU A 505LEU A 514PHE A 516ILE A 527THR A 529TRP A 531CYS A 532PHE A 583GLY A 593ASP A 594PHE A 595 | P06 A 801 |
5CSW_B_P06B801 | 5csw | P06 DB08912(Dabrafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | no annotation | 15 | PHE B 468VAL B 471ALA B 481LYS B 483LEU B 505LEU B 514PHE B 516ILE B 527THR B 529TRP B 531CYS B 532PHE B 583GLY B 593ASP B 594PHE B 595 | P06 B 801 |
5FLC_C_RAPC999 | 5flc | RAP DB00877(Sirolimus) | Homo sapiens;Spodopterafrugiperda | FKBP;SERINE/THREONINE-PROTEIN KINASE MTOR | PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08771(FRB_dom)no annotation | 8 | GLU B2032SER B2035PHE B2039GLY B2040THR B2098TRP B2101TYR B2105PHE B2108 | RAP C 999 |
5FLC_G_RAPG999 | 5flc | RAP DB00877(Sirolimus) | Homo sapiens;Spodopterafrugiperda | FKBP;SERINE/THREONINE-PROTEIN KINASE MTOR | no annotation | 8 | GLU F2032SER F2035PHE F2039GLY F2040THR F2098TRP F2101TYR F2105PHE F2108 | RAP G 999 |
5GPG_A_RAPA301 | 5gpg | RAP DB00877(Sirolimus) | Homo sapiens | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3;SERINE/THREONINE-PROTEIN KINASE MTOR | PF00254(FKBP_C)PF08771(FRB_dom) | 20 | TYR A 135ASP A 146LEU A 162LYS A 170VAL A 171ILE A 172TRP A 175TYR A 198ALA A 206ILE A 208PHE A 216LEU B2031SER B2035ARG B2036PHE B2039THR B2098TRP B2101ASP B2102TYR B2105PHE B2108 | RAP A 301 |
5HES_A_032A401 | 5hes | 032 DB08881(Vemurafenib) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT | PF07714(Pkinase_Tyr)no annotation | 19 | GLY A 23PHE A 27VAL A 30ALA A 43LYS A 45ILE A 66PHE A 68ILE A 80THR A 82TYR A 84ALA A 85SER A 89ASP A 92VAL A 140CYS A 150ASP A 151PHE A 152GLY A 153GLU B 288 | 032 A 401 |
5HES_B_032B401 | 5hes | 032 DB08881(Vemurafenib) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT | no annotation | 16 | CYS B 22GLY B 23PHE B 27VAL B 30ALA B 43LYS B 45ILE B 66ILE B 80THR B 82TYR B 84ALA B 85GLY B 88ASP B 92CYS B 150PHE B 152GLY B 153 | 032 B 401 |
5HI2_A_BAXA801 | 5hi2 | BAX DB00398(Sorafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | PF07714(Pkinase_Tyr) | 20 | ILE A 463VAL A 471ALA A 481LYS A 483GLU A 501VAL A 504LEU A 505ILE A 513LEU A 514THR A 529TRP A 531CYS A 532LEU A 567ILE A 572HIS A 574PHE A 583ILE A 592GLY A 593ASP A 594PHE A 595 | BAX A 801 |
5HIE_A_P06A801 | 5hie | P06 DB08912(Dabrafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | PF07714(Pkinase_Tyr) | 19 | ILE A 463GLY A 464GLY A 466PHE A 468VAL A 471ALA A 481LYS A 483PHE A 498LEU A 505LEU A 514PHE A 516ILE A 527THR A 529TRP A 531CYS A 532PHE A 583GLY A 593ASP A 594PHE A 595 | P06 A 801 |
5HIE_B_P06B801 | 5hie | P06 DB08912(Dabrafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | no annotation | 19 | ILE B 463GLY B 464GLY B 466PHE B 468VAL B 471ALA B 481LYS B 483PHE B 498LEU B 505LEU B 514PHE B 516ILE B 527THR B 529TRP B 531CYS B 532PHE B 583GLY B 593ASP B 594PHE B 595 | P06 B 801 |
5HIE_C_P06C801 | 5hie | P06 DB08912(Dabrafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | no annotation | 19 | ILE C 463GLY C 464GLY C 466PHE C 468VAL C 471ALA C 481LYS C 483VAL C 504LEU C 514PHE C 516ILE C 527THR C 529TRP C 531CYS C 532ASN C 580PHE C 583GLY C 593ASP C 594PHE C 595 | P06 C 801 |
5HIE_D_P06D801 | 5hie | P06 DB08912(Dabrafenib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE B-RAF | no annotation | 20 | ILE D 463GLY D 464GLY D 466PHE D 468VAL D 471ALA D 481LYS D 483PHE D 498VAL D 504LEU D 514PHE D 516ILE D 527THR D 529TRP D 531CYS D 532ASN D 580PHE D 583GLY D 593ASP D 594PHE D 595 | P06 D 801 |
5IZF_E_AZ1E2 | 5izf | AZ1 DB00548(AzelaicAcid) | Homo sapiens;syntheticconstruct | 6J9-ZEU-DAR-ACA-DAR-NH2;CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA | PF00069(Pkinase)no annotation | 7 | GLY A 50GLY A 52SER A 53PHE A 54LYS A 72LEU A 74GLU A 127 | AZ1 E 2 |
5IZJ_F_AZ1F2 | 5izj | AZ1 DB00548(AzelaicAcid) | Homo sapiens | 47P-AZ1-DAR-DAR-DAR;CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA | no annotation | 7 | GLY B 50GLY B 52SER B 53PHE B 54GLY B 55VAL B 57LEU B 74 | AZ1 F 2 |
5IZJ_G_AZ1G2 | 5izj | AZ1 DB00548(AzelaicAcid) | Homo sapiens | 47P-AZ1-DAR-DAR;CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA | PF00069(Pkinase)no annotation | 7 | GLY A 50GLY A 52SER A 53PHE A 54VAL A 57LYS A 72LEU A 74 | AZ1 G 2 |
5J5X_B_AZ1B2 | 5j5x | AZ1 DB00548(AzelaicAcid) | Homo sapiens | 47P-AZ1-DAL-DAR-DAR-DAR-DAR;CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA | PF00069(Pkinase)no annotation | 7 | GLY A 50GLY A 52SER A 53PHE A 54VAL A 57LYS A 72ASP A 184 | AZ1 B 2 |
5LVN_A_ADNA402 | 5lvn | ADN DB00640(Adenosine) | Homo sapiens | 3-PHOSPHOINOSITIDE-DEPENDENT PROTEINKINASE 1 | PF00069(Pkinase) | 11 | LEU A 88GLY A 89VAL A 96ALA A 109VAL A 143LEU A 159TYR A 161ALA A 162GLU A 166GLU A 209LEU A 212 | ADN A 402 |
5LW1_B_ADNB401 | 5lw1 | ADN DB00640(Adenosine) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 8 | no annotation | 9 | ILE B 32GLY B 33VAL B 40ALA B 53ILE B 86MET B 108MET B 111ASN B 114LEU B 168 | ADN B 401 |
5LW1_E_ADNE401 | 5lw1 | ADN DB00640(Adenosine) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 8 | no annotation | 10 | GLY E 33VAL E 40ALA E 53ILE E 86MET E 108LEU E 110MET E 111ASN E 114VAL E 158LEU E 168 | ADN E 401 |
5LW1_H_ADNH401 | 5lw1 | ADN DB00640(Adenosine) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 8 | no annotation | 9 | GLY H 33VAL H 40ALA H 53MET H 108LEU H 110MET H 111ASN H 114VAL H 158LEU H 168 | ADN H 401 |
5MO4_A_NILA601 | 5mo4 | NIL DB04868(Nilotinib) | Homo sapiens | TYROSINE-PROTEINKINASE ABL1 | PF00017(SH2)PF00018(SH3_1)PF07714(Pkinase_Tyr) | 22 | LEU A 267TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305VAL A 308MET A 309ILE A 312LEU A 317VAL A 318ILE A 332ILE A 334PHE A 336MET A 337GLY A 340PHE A 378HIS A 380LEU A 389ALA A 399ASP A 400PHE A 401 | NIL A 601 |
5N3H_A_NCAA401 | 5n3h | NCA DB02701(Nicotinamide) | Cricetulusgriseus | CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA | PF00069(Pkinase) | 10 | LEU A 49VAL A 57ALA A 70VAL A 104MET A 120TYR A 122VAL A 123LEU A 173THR A 183PHE A 327 | NCA A 401 |
5OWR_A_1N1A401 | 5owr | 1N1 DB01254(Dasatinib) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE 10 | PF00069(Pkinase) | 8 | ALA A 63LYS A 65GLU A 81ILE A 110CYS A 113LEU A 164ASP A 175VAL A 314 | 1N1 A 401 |
5P9I_A_1E8A701 | 5p9i | 1E8 DB09053(Ibrutinib) | Homo sapiens | TYROSINE-PROTEINKINASE BTK | PF07714(Pkinase_Tyr) | 17 | LEU A 408GLY A 411VAL A 416ALA A 428LYS A 430MET A 449ILE A 472THR A 474TYR A 476MET A 477GLY A 480CYS A 481ASN A 484LEU A 528SER A 538ASP A 539PHE A 540 | 1E8 A 701 |
5TE0_A_XINA401 | 5te0 | XIN DB09079(Nintedanib) | Homo sapiens | AP2-ASSOCIATEDPROTEIN KINASE 1 | PF00069(Pkinase) | 17 | GLU A 50LEU A 52ALA A 53VAL A 60LEU A 62ALA A 72GLU A 90MET A 94VAL A 104MET A 126PHE A 128CYS A 129GLY A 132GLN A 133ASN A 136LEU A 183CYS A 193 | XIN A 401 |
5VC3_A_DB8A601 | 5vc3 | DB8 DB06616(Bosutinib) | Homo sapiens | WEE1-LIKE PROTEINKINASE | PF00069(Pkinase) | 16 | GLU A 303ILE A 305GLY A 306VAL A 313ALA A 326LYS A 328GLU A 346VAL A 360ASN A 376TYR A 378CYS A 379GLY A 382ASP A 386ASN A 431PHE A 433ASP A 463 | DB8 A 601 |
5W5V_A_ANWA701 | 5w5v | ANW DB01025(Amlexanox) | Homo sapiens | SERINE/THREONINE-PROTEIN KINASE TBK1 | PF00069(Pkinase) | 9 | LEU A 15ALA A 36VAL A 68MET A 86CYS A 89GLY A 92THR A 96MET A 142THR A 156 | ANW A 701 |
5WP1_A_BEZA403 | 5wp1 | BEZ DB03793(BenzoicAcid) | Homo sapiens | MITOGEN-ACTIVATEDPROTEIN KINASE 1 | PF00069(Pkinase) | 4 | GLY A 182PHE A 183ASN A 257LYS A 259 | BEZ A 403 |
5XV7_A_EMHA705 | 5xv7 | EMH DB11363(Alectinib) | Homo sapiens | SERINE-ARGININE (SR)PROTEIN KINASE 1 | no annotation | 16 | ARG A 84LEU A 86GLY A 87VAL A 94ALA A 107PHE A 165VAL A 167LEU A 168GLY A 169HIS A 170LEU A 220VAL A 223TYR A 227LEU A 231ALA A 496ASP A 497 | EMH A 705 |
6FEK_A_ADNA1104 | 6fek | ADN DB00640(Adenosine) | Homo sapiens | PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET | no annotation | 11 | LEU A 730GLY A 731VAL A 738ALA A 756ILE A 788VAL A 804TYR A 806ALA A 807GLY A 810SER A 811LEU A 881 | ADN A1104 |
6HD4_A_STIA604 | 6hd4 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 17 | TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305VAL A 308MET A 309ILE A 312VAL A 318ILE A 332THR A 334PHE A 336MET A 337GLY A 340LEU A 389ALA A 399ASP A 400 | STI A 604 |
6HD4_B_STIB602 | 6hd4 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | None | 18 | LEU B 267TYR B 272VAL B 275ALA B 288LYS B 290GLU B 305VAL B 308MET B 309ILE B 312VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340LEU B 389ALA B 399ASP B 400 | STI B 602 |
6HD6_A_STIA603 | 6hd6 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | PF07714(Pkinase_Tyr) | 17 | LEU A 267TYR A 272VAL A 275ALA A 288LYS A 290GLU A 305MET A 309ILE A 312VAL A 318ILE A 332THR A 334PHE A 336MET A 337GLY A 340LEU A 389ALA A 399ASP A 400 | STI A 603 |
6HD6_B_STIB601 | 6hd6 | STI DB00619(Imatinib) | Mus musculus | TYROSINE-PROTEINKINASE ABL1 | None | 19 | LEU B 267TYR B 272VAL B 275ALA B 288LYS B 290GLU B 305VAL B 308MET B 309ILE B 312VAL B 318ILE B 332THR B 334PHE B 336MET B 337GLY B 340ARG B 381LEU B 389ALA B 399ASP B 400 | STI B 601 |